Solution for oral use Agvantar is used at the following indications:

• primary (congenital) insufficiency of a carnitine;
• secondary insufficiency of a carnitine.

Structure

Active ingredient - levocarnitine (1 ml of solution contains a left carnitine 200 mg).

Excipients: methylparaben (E 218), propylparaben (E 216), sucrose, sorbite (E 420), banana fragrance, water purified.

Contraindication

Hypersensitivity to medicament components.

Dose and duration of treatment the doctor establishes

individually depending on age and a nosological form of a disease. Agvantar to accept inside in 30 minutes prior to food. To use the dosing syringe or a measured glass to dosing. The adult medicament to appoint in an initial dose 1 g a day (5 ml), gradually raising a dose depending on a condition of the patient and shipping. The usual dose of the medicament "Agvantar" for adults makes 1-3 g (5-15 ml) a day divided into 1-3 receptions. The maximum daily dose for adults makes 6 g (30 ml).

to Children Agvantar to appoint

, since a dose of 50 mg/kg a day. Usual doses for children make 50-100 mg/kg a day.

Maximum daily dose makes 3 g. The average course of treatment for adults and children makes 1-3 months. In case of need the course of treatment can be repeated. In case of primary and secondary karnitinovy insufficiency to take the medicament constantly or before elimination of the reason of the last.

by

Feature of use

Pregnant

Teratogenic and embriotoksichesky effect of medicament it is not registered, but due to the lack of adequate controlled clinical trials of use of medicament to pregnant women it is possible only when the expected advantage for mother exceeds possible potential risk for a fruit.

In case of need uses of Agvantar medicine feeding by a breast needs to be stopped for therapy by this drug.

Agvantar can apply

children (full-term and premature newborns) from the first day of life.

Drivers

Drug does not influence speed of response at control of motor transport or other mechanisms.

Side effects

from digestive tract: dispepsichesky disorders, pains in epigastric area, nausea, vomiting, diarrhea.

from the immune system: at individual intolerance can sometimes cause allergic reactions (perhaps, the slowed-down type).

described cases of convulsive attacks at patients both with the previous convulsive activity, and without it. At patients with the previous convulsive activity the frequency and/or weight of convulsive attacks increased.

Existence in composition of medicament of sorbite (E 420) can have soft aperient effect.

Treatment - symptomatic.

to Store

at a temperature not above 25 °C, out of children's reach.

Expiration date - 2 years.